Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression
US6767704B2 · kind B2 · utility
101Cited by
62References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2001 |
| Grant date | Jul 27, 2004 |
| Priority date | — |
| Expiry date | Mar 27, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/988
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Screening and diagnostic reagents, kits and methods for primary and/or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing primary and/or metastatic stomach or esophageal cancer are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.